An Up-to-Date Review on Guillain–Barre Syndrome
Keywords:Acute paralytic polyneuropathy, Demyelination, Guillain–Barre Syndrome, Peripheral nerves
Guillain–Barré syndrome (GBS) is an infrequent acute paralytic polyneuropathy that impacts around one in every 1 lakh people. It can affect both children and adults. GBS is an autoimmune condition of the peripheral nervous system that is developed due to an immune-mediated response to antigens that react with the myelin sheath of peripheral nerves, causing demyelination and/or axonal injury. In serious conditions, GBS can cause respiratory failure and even death also. The treatment with intravenous immunoglobulin and/or plasmapheresis, with an aim to neutralize and dispose the circulating antibodies from the bloodstream, respectively, in addition to supportive measures to maintain motor function of nervous system is presently available.
How to Cite
Copyright (c) 2022 Harpreet Singh, Asheesh Kumar Gupta, Arvind Kumar, Amrita Mishra, Abhishek Sharma, Arun Kumar Mishra, Vikas Kumar Chaudhari
This work is licensed under a Creative Commons Attribution 4.0 International License.
Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.